Part 2 Fees relating to marketing authorisationsF1

United Kingdom Repealed

1. 7Fees for specified pharmaceutical applications
2. 8Decentralised pharmaceutical application where the United Kingdom is the reference member State
3. 9Application for a marketing authorisation for an immunological product
4. 10Decentralised immunological application where the United Kingdom is the reference member State
5. 11Application for a marketing authorisation using identical data
6. 12Application for an exceptional marketing authorisation (pharmaceutical)
7. 13Fees for an application for an exceptional marketing authorisation (immunological)
8. 14Fee for the conversion from an exceptional to a full marketing authorisation
9. 15Application for a marketing authorisation relating to a parallel import
10. 16Application for a variation obtained under a national procedure
11. 17Application for a variation to a marketing authorisation obtained through mutual recognition or decentralised procedures: fees until 1st January 2010
12. 18Application for a variation to a marketing authorisation obtained through mutual recognition or decentralised procedures: fees from 1st January 2010
13. 19Application for an extension to a marketing authorisation
14. 20Decentralised application for an extension where the United Kingdom is the reference member State
15. 21Provision of information relating to the recognition of a United Kingdom marketing authorisation
16. 22Application for the renewal of a national marketing authorisation
17. 23Application for the renewal of a marketing authorisation obtained through mutual recognition or the decentralised procedure
18. 24Registration of a homeopathic remedy
19. 25Annual fees for marketing authorisations
20. 26Auditor’s certificate
21. 27Late payment of annual fees